| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:1317.)
© 2002 American Heart Association, Inc.
Brief Rapid Communication |
From Allgemeines Krankenhaus St Georg, 2. Med. Abteilung, Kardiologie, Hamburg, Germany.
Correspondence to Karl-Heinz Kuck, MD, Allgemeines Krankenhaus St Georg, 2. Med. Abteilung, Kardiologie, Lohmühlenstraße 5, 20099, Hamburg, Germany. E-mail mgoyamd{at}aol.com
| Abstract |
|---|
|
|
|---|
Methods and Results Sixteen patients with paroxysmal AF after pulmonary vein isolation underwent electroanatomic mapping at the RASVC junction during sinus rhythm. Mapping showed sharp potentials (SVC potentials) inside the SVC. Activation spread from the earliest SVC potential (breakthrough) to the rest of the SVC. SVC potentials were found over a large amount of the circumference, suggesting widespread muscle coverage of the SVC. Breakthroughs from the RA to SVC were located anteriorly, laterally, posteriorly, and septally in 3, 4, 10, and 6 patients, respectively. The number of breakthroughs was 1.4±0.5 per patient. Radiofrequency energy was applied with the end point of electrical disconnection. All breakthroughs were eliminated with 3.1±1.7 applications per breakthrough without complications.
Conclusions SVC potentials can be recorded inside the SVC. There are specific breakthroughs from the RA to the SVC that can be identified by electroanatomic mapping. The electrical disconnection of the SVC from the RA is feasible.
Key Words: fibrillation veins catheter ablation mapping
| Introduction |
|---|
|
|
|---|
| Methods |
|---|
|
|
|---|
SVC Mapping Procedure
Before electroanatomic mapping of the SVC, all patients underwent PV isolation as previously described,3 and induction of SVC ectopies by use of isoproterenol and atrial burst pacing was attempted.5 SVC angiography was performed by hand injection. The junction of the convex RA wall and the straight SVC wall on the angiogram was defined as the radiological RASVC junction.
A 7F quadripolar catheter with a location sensor (NAVI-STAR, Biosense-Webster) was used for mapping. Another electrode catheter (REF-STAR, Biosense-Webster) was used as the reference location. A bipolar electrogram from a bipole located inside the coronary sinus was used as the timing reference.
SVC mapping was performed during sinus rhythm. The radiological RASVC junction was used as the anatomic reference. From that point, the mapping catheter was advanced until no signals were recorded. Sequential recording was then performed at multiple points by dragging the mapping catheter along the SVC circumference to reconstruct a three-dimensional activation map.
Measurements and Definitions
The local activation time was annotated manually at the onset of the bipolar spiky component inside the SVC (filter setting 10 to 400 Hz). If double potentials were recorded at the radiological RASVC junction, the first and second potential represented the activation of the RA and SVC (SVC potential), respectively. This definition was based on the fact that only the second component could be traced by mapping into the SVC. Distally, the end of the muscle was defined by the absence of a recordable clear signal.
We measured and calculated the location of the earliest activation site (breakthrough), the total activation time (the duration from the earliest to the latest activation site), the distribution of SVC potentials, and the number of breakthroughs. If there was a second early SVC potential recording site or an apparent change of intra-SVC activation sequence after the elimination of the first breakthrough, we defined a second breakthrough. To indicate the location, we divided the SVC into four aspects: anterior, lateral, posterior, and septal. The SVC diameter was measured on the electroanatomic map and compared with that determined from SVC angiography.
Catheter Ablation
Before ablation, an additional multipolar catheter was positioned in the SVC for continuous monitoring of SVC potentials. RF applications were delivered at the junction, targeting the earliest SVC activation on the electroanatomic map. A temperature control mode with a maximum temperature setting of 50° C and maximum power setting of 30 watts was used. The end point was the elimination or dissociation of all SVC potentials.
Follow-Up and Statistical Analysis
Surface ECG, echocardiography, Holter monitoring, and clinical follow-up were obtained after the procedures. All data are expressed as mean±SD. Statistical comparisons were performed using Students t test for paired values. A probability value <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
Baseline Electrophysiological Study and PV Isolation
Before electroanatomic mapping, isolation of all PVs was confirmed. During sinus rhythm, the SVC potentials were fused with the local RA signals at some discrete part of the RASVC junction. From this site, the activation spread to the rest of the SVC.
Atrial ectopies originating from the SVC were recorded in 6 patients during the procedures. During ectopy from the SVC, there was a reversal of far-field RA activity and SVC spike potential (Figure 1A), resulting in an activation sequence from the distal SVC sleeve to the RASVC junction.
|
Electroanatomic Mapping
In 16 patients, 107±32 points were sampled. In all patients, SVC potentials were recorded, and double or multiple-component potentials were recorded around the RASVC junction (Figure 2). SVC potentials were recordable over a large amount of the SVC circumference. Conduction time was 41.8±15.6 ms (range: 23 to 75 ms). Breakthroughs were located in the anterior aspect of the RASVC junction in 3, lateral in 4, posterior in 10, and septal region in 6 patients. The number of breakthroughs was 1.4±0.5 per patient (range: 1 to 2). The SVC diameters measured by electroanatomic mapping and angiography were 23.7±3.4 mm and 22.5±4.1 mm (not significant), respectively.
|
Catheter Ablation
Sequential RF applications that targeted the earliest SVC potential were delivered at the RASVC junction. RF application at the first site eliminated all SVC potentials in 11 patients. In the remaining 5 patients, a second breakthrough was observed. In these patients, ablation at the second breakthrough resulted in an abrupt disappearance of distal SVC potentials (Figure 1B). The mean number of RF applications was 4.0±1.0 (range: 2 to 7) per patient and 3.1±1.7 (range: 2 to 6) per breakthrough. All breakthroughs were successfully ablated by conventional RF energy.
After electrical disconnection, no ectopies conducted to the RA were observed. Independent SVC rhythms with cycle lengths of 1700 ms and 2140 ms were observed in 2 patients.
Follow-Up
Sinus rhythm was maintained in 13 of 16 patients (81%) during 12.6±0.8 months of follow-up. The number of supraventricular ectopies recorded by Holter monitoring decreased from 1431±1635 before ablation to 97±73 after ablation. No complications occurred during and after the procedures.
| Discussion |
|---|
|
|
|---|
There are several reports about the extension of atrial muscle into the SVC7,8 and its excitability.9,10 The question of anatomic inputs from the RA to the SVC, however, has not been addressed. Yeh et al11 described immunohistochemical and ultrastructural findings in the RA and SVC. They mentioned differences between and within the levels of the SVC, including the size and assembly of cardiomyocytes and the distribution of gap junctions. These differences, especially within the level, might create specific breakthroughs from an anatomic standpoint.
Our target of RF energy was the breakthroughs, not the crista terminalis. In some patients (Figure 1B), however, double potentials were recorded at the anterior aspect of the RASVC junction, which was close to the successful ablation point. It is possible that these double potential recording sites are identical to the distal crista terminalis, as described by Chen et al.6
According to the study by Tsai et al5, ectopies from the SVC contributed to the initiation of AF in 6% of their patients. This number could be even higher after PV isolation. It has been suggested that complete isolation of the PVs is more effective than ablation of single foci inside the PVs. This suggests that complete RASVC disconnection may be more effective than focal ablation inside the SVC.
It was possible that far-field potentials from the right side PV could be recorded inside the SVC even after electrical disconnection, which could lead to inappropriate energy delivery. In the present study, we performed the SVC isolation after PV isolation, and therefore the likelihood of this misleading situation was minimized.
Our findings have clinical implications. Electrical disconnection of the SVC from the RA is feasible, and detailed mapping at the RASVC junction optimizes RF delivery by directing energy at specific segments and avoiding unnecessary applications.
Limitations
SVC angiography was used to define the junction between the RA and the SVC in the present study. Intracardiac echocardiography, however, might better define this junction. The number of the study patients was small, and therefore further larger studies and a longer follow-up are necessary to clarify the long-term effectiveness and safety of this procedure.
Conclusion
SVC potentials similar to PV potentials are observed over a large extent of the SVC circumference. Specific breakthroughs from the RA to the SVC can be identified by electroanatomic mapping. The electrical disconnection of the SVC from the RA is feasible.
Received June 12, 2002; revision received July 22, 2002; accepted July 24, 2002.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
X.-H. Wang, X. Liu, Y.-M. Sun, H.-F. Shi, L. Zhou, and J.-N. Gu Pulmonary vein isolation combined with superior vena cava isolation for atrial fibrillation ablation: a prospective randomized study Europace, May 1, 2008; 10(5): 600 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Callahan and A. Natale Procedural End Points in Pulmonary Vein Antrum Isolation: Are We There Yet? Circulation, January 15, 2008; 117(2): 131 - 133. [Full Text] [PDF] |
||||
![]() |
D. G. Katritsis and A. J. Camm Catheter ablation of atrial fibrillation: do we know what we are doing? Europace, November 1, 2007; 9(11): 1002 - 1005. [Full Text] [PDF] |
||||
![]() |
H. Liu, K.-T. Lim, C. Murray, and R. Weerasooriya Electrogram-guided isolation of the left superior vena cava for treatment of atrial fibrillation Europace, September 1, 2007; 9(9): 775 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Thornton, M. Rivero-Ayerza, J. M. Mekel, and L. Jordaens Bidirectional superior vena cava: right atrial conduction delay during tachycardia Europace, May 1, 2007; 9(5): 302 - 304. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamamoto, H. Dobrzynski, J. Tellez, R. Niwa, R. Billeter, H. Honjo, I. Kodama, and M. R. Boyett Extended atrial conduction system characterised by the expression of the HCN4 channel and connexin45 Cardiovasc Res, November 1, 2006; 72(2): 271 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tanner, G. Hindricks, R. Kobza, A. Dorszewski, P. Schirdewahn, C. Piorkowski, J.-H. Gerds-Li, and H. Kottkamp Trigger Activity More Than Three Years After Left Atrial Linear Ablation Without Pulmonary Vein Isolation in Patients With Atrial Fibrillation J. Am. Coll. Cardiol., July 19, 2005; 46(2): 338 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kholova and J. Kautzner Morphology of Atrial Myocardial Extensions Into Human Caval Veins: A Postmortem Study in Patients With and Without Atrial Fibrillation Circulation, August 3, 2004; 110(5): 483 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Cappato, S. Negroni, D. Pecora, S. Bentivegna, P. P. Lupo, A. Carolei, C. Esposito, F. Furlanello, and L. De Ambroggi Prospective Assessment of Late Conduction Recurrence Across Radiofrequency Lesions Producing Electrical Disconnection at the Pulmonary Vein Ostium in Patients With Atrial Fibrillation Circulation, September 30, 2003; 108(13): 1599 - 1604. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |